Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 583

1.

Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children.

Saarinen-Pihkala UM, Lanning M, Perkkiö M, Mäkipernaa A, Salmi TT, Hovi L, Vettenranta K.

Med Pediatr Oncol. 2000 May;34(5):319-27.

PMID:
10797353
[PubMed - indexed for MEDLINE]
2.

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.

Mayordomo JI, Rivera F, Díaz-Puente MT, Lianes P, Colomer R, López-Brea M, López E, Paz-Ares L, Hitt R, García-Ribas I, et al.

J Natl Cancer Inst. 1995 Jun 7;87(11):803-8.

PMID:
7540696
[PubMed - indexed for MEDLINE]
3.

Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.

Thomas X, Boiron JM, Huguet F, Reman O, Sutton L, Turlure P, Garban F, Gardin C, Espinouse D, Boulat O, Lhéritier V, Fiere D; Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group).

Hematol J. 2004;5(5):384-94.

PMID:
15448664
[PubMed - indexed for MEDLINE]
4.

A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.

Welte K, Reiter A, Mempel K, Pfetsch M, Schwab G, Schrappe M, Riehm H.

Blood. 1996 Apr 15;87(8):3143-50.

PMID:
8605328
[PubMed - indexed for MEDLINE]
Free Article
5.

Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.

Michel G, Landman-Parker J, Auclerc MF, Mathey C, Leblanc T, Legall E, Bordigoni P, Lamagnere JP, Demeocq F, Perel Y, Auvrignon A, Berthou C, Bauduer F, Pautard B, Schneider P, Schaison G, Leverger G, Baruchel A.

J Clin Oncol. 2000 Apr;18(7):1517-24.

PMID:
10735900
[PubMed - indexed for MEDLINE]
6.

Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.

Ravaud A, Chevreau C, Cany L, Houyau P, Dohollou N, Roché H, Soubeyran P, Bonichon F, Mihura J, Eghbali H, Tabah I, Bui BN.

J Clin Oncol. 1998 Sep;16(9):2930-6.

PMID:
9738560
[PubMed - indexed for MEDLINE]
7.

Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.

Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME; Children's Cancer Group.

J Clin Oncol. 2003 Apr 15;21(8):1612-7.

PMID:
12697887
[PubMed - indexed for MEDLINE]
8.

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.

Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T, Relling MV, Ribeiro RC, Crist WM, Evans WE.

N Engl J Med. 1997 Jun 19;336(25):1781-7.

PMID:
9187068
[PubMed - indexed for MEDLINE]
Free Article
9.

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin.

Yau JC, Neidhart JA, Triozzi P, Verma S, Nemunaitis J, Quick DP, Mayernik DG, Oette DH, Haynes FA, Holcenberg J.

Am J Hematol. 1996 Apr;51(4):289-95.

PMID:
8602629
[PubMed - indexed for MEDLINE]
10.

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Witz F, Sadoun A, Perrin MC, Berthou C, Brière J, Cahn JY, Lioure B, Witz B, François S, Desablens B, Pignon B, Le Prisé PY, Audhuy B, Caillot D, Casassus P, Delain M, Christian B, Tellier Z, Polin V, Hurteloup P, Harousseau JL.

Blood. 1998 Apr 15;91(8):2722-30.

PMID:
9531581
[PubMed - indexed for MEDLINE]
Free Article
11.

Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.

Alvarado Ibarra ML, Borbolla Escoboza JR, López-Hernández MA, González-Avante CM, FloresChapa JD, Trueba Christy E, Anaya Cuellar I.

Rev Invest Clin. 1999 Mar-Apr;51(2):77-80.

PMID:
10410585
[PubMed - indexed for MEDLINE]
12.

Recombinant human granulocyte-macrophage colony-stimulating factor in children with chemotherapy-induced neutropenia.

Saarinen UM, Hovi L, Riikonen P, Pihkala J, Juvonen E.

Med Pediatr Oncol. 1992;20(6):489-96.

PMID:
1435519
[PubMed - indexed for MEDLINE]
13.

Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies.

Lydaki E, Bolonaki E, Stiakaki E, Dimitriou H, Kalmantis T, Kalmanti M.

Pediatr Hematol Oncol. 1995 Nov-Dec;12(6):551-8.

PMID:
8589000
[PubMed - indexed for MEDLINE]
15.

Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma.

Dinçol D, Samur M, Pamir A, Sencan O, Akbulut H, Yalçin B, Onur H, Demirkazik A, Senler FC, Içli F.

Cancer. 2000 May 1;88(9):2033-6.

PMID:
10813713
[PubMed - indexed for MEDLINE]
16.

Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia.

Clarke V, Dunstan FD, Webb DK.

Med Pediatr Oncol. 1999 May;32(5):331-5.

PMID:
10219333
[PubMed - indexed for MEDLINE]
17.

High-dose cytarabine-containing chemotherapy with or without granulocyte colony-stimulating factor for children with acute leukemia.

Chen SH, Liang DC, Liu HC.

Am J Hematol. 1998 May;58(1):20-3.

PMID:
9590144
[PubMed - indexed for MEDLINE]
18.

Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study.

Burdach SE, Müschenich M, Josephs W, Frisch J, Schulz G, Jürgens H, Göbel U.

Cancer. 1995 Aug 1;76(3):510-6.

PMID:
8625134
[PubMed - indexed for MEDLINE]
19.

Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.

Marina NM, Shema SJ, Bowman LC, Rodman J, Douglass EC, Furman WL, Pappo A, Santana VM, Hudson M, Meyer WH, et al.

Med Pediatr Oncol. 1994;23(4):328-34.

PMID:
8058003
[PubMed - indexed for MEDLINE]
20.

Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.

Harousseau JL, Witz B, Lioure B, Hunault-Berger M, Desablens B, Delain M, Guilhot F, Le Prise PY, Abgrall JF, Deconinck E, Guyotat D, Vilque JP, Casassus P, Tournilhac O, Audhuy B, Solary E.

J Clin Oncol. 2000 Feb;18(4):780-7.

PMID:
10673519
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk